BRCA1 and/or BRCA2 mutation carriers are at a lifetime risk of developing breast cancer of up to 85%, and for ovarian cancer their lifetime risk is reportedly between 20% and 40% (33, 34). This evidence concerns the gene BRCA1 and ovarian cancer.